Safety Evaluation and Risk Assessment Using Immunotoxicology Methods

Abbas, A. K. , Lichtman, A. H. , Pober, J. S. 1991. Cellular and molecular immunology, pp. 205–211. Philadelphia: W. B. Saunders.

Basketter, D. A. , Scholes, E. W. , Kimber, I. , Botham, P. A. , Hilton, J. , Miller, K. , Robbins, M. C. , Harrison, P. T. C. , and Waite, S. J. 1991. Inter-laboratory evaluation of the local lymph node assay with 25 chemicals and comparison with guinea pig test data. Toxicol. Methods 1:30–43.

Basketter, D. A. , Selbie, E. , Scholes, E. W. , Lees, D. , Kimber, I. , and Botham, P. A. 1993. Results with OECD recommended positive control sensitizers in the maximization. Buehler and local lymph node assays. Food Chem. Toxicol. 31:63–67.

Basketter, D. A. , Scholes, E. W. , and Kimber, I. 1994. The performance of the local lymph node assay with chemicals identified as contact allergens in the human maximization test. Food Chem. Toxicol. 32:543–547.

Basketter, D. A. , Gerberick, G. F. , Kimber, J. , and Loveless, S. E. 1996. The local lymph node assay: a viable alternative to currently accepted skin sen-sitization tests. Food Chem. Toxicol. 34:985–997.

Bekesi, J. G. , Holland, J. F. , Anderson, H. A. , Fischbein, A. S. , Rom, W. , Wolff, M. S. , and Selikoff, I. J. 1978. Lymphocyte function of Michigan dairy farmers exposed to polybrominated biphenyls. Science 199:1207–1209.

Bigazzi, P. E. 1988. Autoimmunity induced by chemicals. J. Toxicol. clin. Toxicol. 26:125–156.

Blaikie, L. , Morrow, T. , Wilson, A. P. , Hext, P. , Hartrop, P. J. , Rattray, N. J. , Woodcock, D. , and Botham, P. A. 1995. A two-center study for the evaluation and validation of an animal model for the assessment of the potential of small molecular weight chemicals to cause respiratory allergy. Toxicology 96:37–50.

Bloom, J. C. , Thiem, P. A. , and Morgan, D. G. 1987. The role of conventional pathology and toxicology in evaluating the immunotoxic potential of xenobi-otics. Toxicol. Pathol. 15:283–293.

Botham, P. A. , Basketter, D. A. , Maurer, T. , Mueller, K. D. , Potokar, M. , and Bontinck, W J. 1991. Skin sensitization—A critical review of predictive test methods in animals and man. Food Chem. Toxicol. 29:275–286.

Boyer, I. J. 1989. Toxicity of dibutyltin, tributyltin, and other organotin compounds to humans and to experimental animals. Toxicology 55:253–298.

Buehler, E. V. 1965. Delayed contact hypersensitivity in the guinea pig. Arch. Dermatol. 91:171–175.

Buehler, E. V. 1985. A rationale for the selection of occlusion to induce and elicit delayed contact hypersensitivity in the guinea pig. A prospective test. Curr. Probl. Dermatol. 14:39–58.

Chin, Y.-H. , Falanga, V. , Taylor, J. R. , Cai, J.-P. , and Bax, J. 1990. Adherence of human helper/memory T-cell subsets to psoriatic dermal endothelium. J. Invest. Dermatol. 94:413–417.

Cohen, I. R. , and Miller, A. 1994. Autoimmune disease models: A guidebook. San Diego: Academic Press.

Condemi, J. J. 1992. The autoimmune diseases. J. Am. Med. Assoc. 268:2882–2892.

Dean, J. H. , and Murray, M. J. 1991. Toxic responses of the immune system. In Casarett and Doull's toxicology: The basic science of poisons, eds. C. D. Klaassen , M. O. Amdur , and J. Doull , 4th ed. pp. 282–333. New York: Macmillan.

Dean, J. H. , Cornacoff, J. B. , Barbolt, T. A. , Gossett, K. A. , and LaBrie, T. 1992. Preclinical toxicity of IL-4; A model for studying protein therapeutics. Int. J. Imm unopharmacol. 14:391–397.

Descotes, J. 1986. Pseudo-allertic drug reactions, Clin. Res. Pract. Drug Reg. Affairs 4:75–84.

Descotes, J. 1992. The popliteal lymph node assay; A tool for studying the mechanisms of drug-induced autoimmune disorders. Toxicol. Lett. 64/65:101–107.

Du, D. L. , Volpe, D. A. , Greishaber, C. K. , and Murphy, M. J., Jr. 1990. In vitro myelotoxicity of 2′,3′-dideoxynucleosides on human hematopoietic progenitor Cells. Exp. Hematol. 18:832–836.

Fischer, E. I. , and Hincks, J. R. 1992. Characterization of the in vitro myelotoxicity in WIN 59075 (SR4233). Proc. Am. Assoc. Cancer Res. 33:502.

Fischer, E. I. , Hoekstra, S. J. , Roberts, A. E. , and Hincks, J. R. 1995. In vitro myelotoxicity studies of the thioxanthone anti-cancer agent, WIN 33377, to support a clinical pharmacokinetically guides dose escalation. Proc. Am. Assoc. Cancer Res. 36:368.

Gerberick, G. F. , House, R. V. , Fletcher, E. , and Ryan, C. A. 1992. Examination of the local lymph node assay for use in contact sensitization risk assessment. Fundam. Appl. Toxicol. 19:438–445.

Gerberick, G. F. , Cruse, L. W. , Ryan, C. A. , Sikorski, E. E. , Miller, C. M. , and Ridder, G. M. 1996. Differential expression of T cell activation markers (CD62L, CD44, CD45RB, CD25) in draining lymph nodes of mice following exposure to allergens and irritants. Toxicologist 30:95.

Harvey, P. , Kirshner, J. , and Early, A. P. 1984. Leukemia cell cultures. In Hematopoiesis, ed. W. Golde , pp. 243–268. New York: Churchill-Livingston.

Hincks, J. R. , Adlakha, A. , Cook, C. A. , Johnson, C. S. , Furmanski, P. , and Gibson, N. W 1990. In vitro studies on the mechanism of action of hepsulfam in chronic myelogenous leukemia patients. Cancer Res. 50:7559–7563.

Holsapple, M. P. , Munson, A. E. , Munson, J.A. , and Bick, P. H. 1983. Suppression of cell-mediated immunocompetence after subchronic exposure to diethylstilbestrol in female B6C3F1 mice. J. Pharmacol. Exp. Ther. 227:130–138.

Jalkanen, S. T. , and Butcher, E. C. 1985. In vitro analysis of the homing properties of human lymphocytes: Developmental regulation of functional receptors for high endothelial venules. Blood 66:577–582.

Kammuller, M. E. , Thomas, C. , De Bakker, J. M. , Bloksma, N. , and Seinen, W. 1989. The popliteal lymph node assay in mice to screen for the immune disregulating potential of chemicals—A preliminary study. Int. J. Immunopharmacol. 11:293–300.

Karol, M. H. , Stadler, J. , and Magreni, C. 1985. Immunotoxicologic evaluation of the respiratory system: Animal models for immediate-and delayed-onset pulmonary hypers ensitivity. Fundam. Appl. Toxicol. 5:459–472.

Kimber, I. , and Basketter, D. A. 1992. The murine local lymph node assay: A commentary on collaborative studies and new directions. Food Chem. Toxicol. 30:165–169.

Kimber, I. , Mitchell, J. A. , and Griffin, A. C. 1986. Development of a murine local lymph node assay for the determination of sensitizing potential. Food Chem. Toxicol. 24:585–586.

Kimber, I. , Hilton, J. , and Weisenberger, C. 1989. The murine local lymph node assay for identification of contact allergens: A preliminary evaluation of in situ measurement of lymphocyte proliferation. Contact Dermatitis 21:215–220.

Kimber, I. , Hilton, J. , and Botham, P. A. 1990. Identification of contact allergens using the murine local lymph node assay: Comparisons with the Buehler occluded patch test in guinea pigs. J. Appl. Toxicol. 10:173–180.

Kimber, I. , Dearman, R. J. , Scholes, E. W. , and Basketter, D. A. 1994. The local lymph node assay: Developments and applications. Toxicology 93:13–31.

Kimber, I. , Hilton, J. , Dearman, R. J. , Gerberick, G. F. , Ryan, C. A. , Basketter, D A. , Scholes, E. W. , Ladics, G S. , Loveless, S. E. , and House, R. V. 1995. An international evaluation of the murine local lymph node assay and comparison of modified procedures. Toxicology 103:63–73.

Kuper, C. F. , Schuurman, H. J. , and Vos, J. G. 1995. Pathology in immunotox-icology. In Methods in immunotoxicology, eds. G. R. Burleson , J. H. Dean , and A. F. Munson , pp. 397–436. New York: Wiley-Liss.

Lew, F. , Tsang, P. , Holland, J. F. , Warner, N. , Selikoff, I. J. , and Bekesi, J. G. 1986. High frequency of immune dysfunctions in asbestos workers and in patients with malignant mesothelioma. J. Clin. Immunoll. 6:225–233.

Loveless, S. E. , Ladics, G. S. , Gerberick, G. F. , Ryan, C. A. , Basketter, D. A. , Scholes, E. W. , House, R. V. , Hilton, J. , Dearman, R. J. , and Kimber, I. 1996. Further evaluation of the local lymph node assay in the final phase of an international collaborative trial. Toxicology 108:141–152.

Luster, M. I. , Munson, A. E. , Thomas, P. T. , Holsapple, M. P. , Fenters, J. D. , White, K. L. , Lauer, L. D. , Germolec, D. R. , Rosenthal, G. J. , and Dean, J. H. 1988. Development of a testing battery to assess chemical-induced immuno-toxicity. National Toxicology Program's criteria for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 10:2–19.

Luster, M. I. , Portier, C. , Pait, D. G. , White, K. L. , Gennings, C. , Munson, A. E. , and Rosenthal, G. J. 1992. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18:200–210.

Luster, M. I. , Porteir, C. , Pait, D. G. , Rosenthal, G. J. , Germolec, D. R. , Corsini, E. Blaylock, B. L. , Pollock, P. , Kouchi, Y. , Craig, W. , White, K. L. , Munson, A. E. , and Comment, C. E. 1993. Risk assessment in immunotoxicology II. Relationship between immune and host resistance tests. Fundam. Appl. Toxicol. 21:71–82.

Magnusson, B. , and Kligman, A. M. 1969. The identification of contact allergens by animal assay. The guinea pig maximization test. J. Invest. Derma-tol. 52:268–276.

Montelius, J. , Wahlkvist, H. , Boman, A. , Fernstrom, P. , Grabergs, L. , and Wahlberg, J. E. 1994. Experience with the murine local lymph node assay: Inability to discriminate between allergens and irritants. Acta Dermatol. Venereal. (Stockh.) 74:22–27.

National Academy of Science . 1983. Risk Assessment in the Federal Government: Managing the Process. Washington, DC: National Academy Press.

National Research Council . 1992. Biologic markers in immunotoxicology, pp. 33–82. Washington, DC: National Academy Press.

Office of Technology Assessment . 1991. Identifying and Controlling Immuno-toxic Substances—Background Paper. OTA-BP-BA-75. Washington, DC: U.S. Government Printing Office.

Pestka, J. J. , Tai, J. H. , Witt, M. F. , Dixon, D. E. , and Forsell, J. H. 1987. Suppression of immune response in the B6C3F1 mouse after dietary exposure to the fusarium mycotoxins deoxyvalenol (vomitoxin) and zearanelone. Food Chem. Toxicol. 25:297–304.

Rose, N. R. , and Mackay, I. R. 1992. The immune response in autoimmunity and autoimmune disease. In The autoimmune disease II, eds. N. R. Rose and I. R. Mackay , pp. 1–26. San Diego: Academic Press.

Rosenberg, N. L. , Ringel, S. P. , and Kotzin, B. L. 1987. Experimental autoimmune myositis in SJL/J mice. Clin. Exp. Immunol. 68:117–129.

Schuurman, H. J. , Kuper, C. F. , and Vos, J. G. 1994. Histopoathology of the immune system as a tool to assess immunotoxicity. Toxicology 86:187–212.

Shoenfeld, Y. , and Isenberg, D. 1989. The mosaic of autoimmunity. Amsterdam: Elsevier.

Sikorski, E. E. , Gerberick, G. F. , Ryan, C. A. , Miller, C. M. , and Ridder, G. M. 1996. Phenotypic analysis of lymphocyte subpopulations in lymph nodes draining the ear following exposure to contact allergens and irritants. Fundam. Appl. Toxicol. 34:25–35.

Tubbs, R. R. , Gephardt, G. N. , and Petras, R. E. 1986. Atlas of immunohistol-ogy. Chicago: American Society of Clinical Pathology Press.

Urso, P. , and Gengozian, N. 1980. Depressed humoral immunity and increased tumor incidence in mice following in utero exposure to benzo(a)pyrene. J. Toxicol. Environ. Health 6:569–576.

van der Laan, J. W. , and Dean, J. H. 1996. Immunotoxicity of Pharmaceuticals: An introduction to the workshop. Drug Information J. 30:269–270.

van der Laan, J. W. , Van Loveren, H. , Vos, J. G. , Dean, J. H. , and Hastings, K. L. 1997. Immunotoxicity of Pharmaceuticals. Current knowledge, testing strategies, risk evaluation and consequences for human health. Drug information Joumal. 31:1301–1305.

van Loveren, H. , Vos, J. G. , and De Waal, E. J. 1996. Testing immunotoxicity of chemicals as a guide for testing approaches for Pharmaceuticals. Drug information Assoc. J. 30:275–279.

Verdier, F. , Chazal, I. , and Descotes, J. 1994. Anaphylaxis models in the guinea pig. Toxicology 93:55–61.

White, K. L. , Gennings, D. , Murray, M. J. , and Dean, J. H. 1994. Rat immuno-toxicology validation study. Toxicol. In Vitro. 8:957–961.

Wolfgram, L. J. , Beisel, K. W. , and Rose, N. R. (1985. Heart-specific autoanti-bodies following murine coxsackie virus B3 myocarditis. J. Exp. Med. 161:1112–1121.